Hearing the unheard: single CT volume surrogates of regional lung function
Abstract
Details
- Title: Subtitle
- Hearing the unheard: single CT volume surrogates of regional lung function
- Creators
- Muhammad Faizyab Ali Chaudhary
- Contributors
- Joseph M. Reinhardt (Advisor)Eric A. Hoffman (Committee Member)Gary E. Christensen (Committee Member)Sarah E. Gerard (Committee Member)Edward Sander (Committee Member)
- Resource Type
- Dissertation
- Degree Awarded
- Doctor of Philosophy (PhD), University of Iowa
- Degree in
- Biomedical Engineering
- Date degree season
- Spring 2024
- DOI
- 10.25820/etd.007501
- Publisher
- University of Iowa
- Number of pages
- xxxv, 171 pages
- Copyright
- Copyright 2024 Muhammad Faizyab Ali Chaudhary
- Grant note
- The research work conducted during my Ph.D. was supported in part by the grant R01HL142625 from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) and by a grant from The Roy J. Carver Charitable Trust. SPIROMICS was supported by contracts from the NIH/NHL BI (HHSN268200900013C, HHSN268200900014C, HHSN 268200900015C, HHSN268200900016C, HHSN268200900 017C, HHSN268200900018C, HHSN268200900019C, HHS N268200900020C), grants from the NIH/NHLBI (U01 HL1 37880 and U24 HL141762), and supplemented by contributions made through the Foundation for the NIH and the COPD Foundation from AstraZeneca/MedImmune; Bayer; Bellerophon Therapeutics; Boehringer-Ingelheim Pharmaceuticals, Inc.; Chiesi Farmaceutici S.p.A.; Forest Research Institute, Inc.; GlaxoSmithKline; Grifols Therapeutics, Inc.; Ikaria, Inc.; Novartis Pharmaceuticals Corporation; Nycomed GmbH; ProterixBio; Regeneron Pharmaceuticals, Inc.; Sanofi; Sunovion; Takeda Pharmaceutical Company; and Theravance Biopharma and Mylan
- Comment
- This thesis has been optimized for improved web viewing. If you require the original version, contact the University Archives at the University of Iowa: https://www.lib.uiowa.edu/sc/contact/
- Language
- English
- Date submitted
- 04/09/2024
- Description illustrations
- Illustrations, tables, graphs, charts
- Description bibliographic
- Includes bibliographical references (pages 132-158).
- Public Abstract (ETD)
Human lungs help us breathe around the clock, and their normal function is very tightly regulated by a concert of various mechanisms. This intricate harmony can be disrupted in countless different ways, and these disruptions can often lead to some very complicated lung disorders. One such complication of the lungs is the chronic obstructive pulmonary disease (COPD), which presents in different yet complicated ways. One of the emerging clinical tools for understanding and characterizing COPD is computed tomography (CT) imaging which allows us to visualize lung tissues and the airways under diseased conditions. Computed tomography imaging has helped the clinicians devise various interventions for managing COPD. Computational tools have also been used to automatically analyze CT scans of COPD patients and several clinically relevant outcomes have thus been developed for understanding disease stage and therapeutic response. One can easily wonder: are there any well-known CT biomarkers? if there are any, have they been validated and tested in diverse clinical conditions? The answer to the first question is yes: CT scans acquired at full-exhale and full-inhale have been able to provide some clinically relevant measures of the overall and local lung function. The most interesting thing about these biomarkers, that helps them stand apart from other approaches, is their ability to localize lung regions impacted by COPD – locality. This comes with a drawback: these approaches require at least two CT scans, however, in most clinical settings CT scans are acquired at a single volume.
While the single volume CT data continues to grow very rapidly around the world, there are not local CT imaging measures that could help characterize lung function. We thought to ourselves, if the very recent generative models can be used to transform human faces to sketches or doodles, or if horses can be converted into zebras, why cannot we use generative modeling for synthesizing CT scans at one volume from another? This could be really useful, since we could then synthesize scans where only one CT scan was acquired and perform the functional analysis. This thesis is all about the development of such generative models. It takes you through the process of estimating functional lung imaging measures using single CT volumes using deep generative modeling.
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Craniofacial Anomalies Research Center
- Record Identifier
- 9984647257502771